A recent study sponsored by Massachusetts General Hospital in collaboration with the National Multiple Sclerosis Society and Pillsy Inc. was […]
A recent study led in Italy was organized to investigate the question whether autologous hematopoietic stem cell transplantation (aHSCT) can […]
The term “off-label” is described by the FDA as an unapproved use of an approved drug. Recently, a study conducted […]
Duke University, through the Immune Tolerance Network, is offering a multicenter, Phase III interventional clinical trial examining the efficacy of […]
Monash University investigators are in pursuit for a new treatment for multiple sclerosis (MS) that they believe may actually reverse […]
Researchers from Trinity College Dublin have made an important discovery that may lead to more effective multiple sclerosis (MS) treatments […]
GeNeuro, a European biopharmaceutical company developing new treatments, focused on stopping causal factors driving the progression of neurodegenerative and autoimmune […]
Boutique short-seller Kerrisdale Capital Management (KCM), a private investment manager, recently published a report explaining why they have taken a […]
Case Western Reserve University researchers have developed a drug known as Myeliviz that could make it easier for doctors to […]
Oklahoma Medical Research Foundation (OMRF) researchers are investigating how an FDA—approved multiple sclerosis drug affects vision loss. It so happens […]
